Advertisement

Picture EBD Group BioPharm America 2017 BPA Boston MA September 600x60px

News > All

Total search results: 7140 | Ordered by Date (descending)
1 2 3 ... 70 71 72  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Ionis Pharmaceuticals, Inc.. (8/11/17). "Press Release: Ionis to Independently Advance Inotersen and Ionis-FB-L Rx". Carlsbad, CA. 2017-08-11
Alcobra Ltd.. (8/11/17). "Press Release: Alcobra Announces Second Quarter 2017 Financial Results and Provides Corporate Update". Tel Aviv. 2017-08-11
Oxford BioMedica plc. (8/11/17). "Press Release: Oxford BioMedica Announces a £2 Million Two-year Collaboration Co-funded by Innovate UK". London. 2017-08-11
Evotec AG. (8/10/17). "Press Release: Evotec Announces First Half Year 2017 Results and Corporate Update". Hamburg. 2017-08-10
Eurofins Scientific. (8/10/17). "Press Release: Eurofins Strengthens Its Footprint in Food and Agroscience Testing in Japan with New Acquisitions". 2017-08-10
Mologen AG. (8/10/17). "Press Release: Important Milestones Achieved in Clinical Trials during the First Half 2017". Berlin. 2017-08-10
Caisse de Dépot et Placement du Québec (CDPQ). (8/10/17). "Press Release: CDPQ to Acquire Significant Minority Stake in Sebia, a Global Leader in the Medical Diagnostics Sector, from Astorg and Montagu". Paris & Montréal. 2017-08-10
Orchard Therapeutics Ltd.. (8/10/17). "Press Release: Orchard Therapeutics Appoints Mark Rothera as CEO". London. 2017-08-10
Pieris Pharmaceuticals, Inc.. (8/10/17). "Press Release: Pieris Pharmaceuticals Appoints Allan Reine, M.D., as Chief Financial Officer". Boston, MA. 2017-08-10
Basilea Pharmaceutica Ltd.. (8/10/17). "Press Release: Basilea Reports Improved Financial Results in Half-year 2017 Driven by Growing Product Sales, Significant Progress on Partnering and Development Programs". Basel. 2017-08-10
Biotecnol Ltd.. (8/10/17). "Press Release: Biotecnol and CRUK to Trial New Immuno-oncology Treatment for Advanced Solid Tumours". 2017-08-10
Roivant Sciences GmbH. (8/9/17). "Press Release: Roivant Sciences Raises $1.1 Billion in Equity Investment Led by SoftBank Vision Fund". Basel & London. 2017-08-09
Genmab A/S. (8/9/17). "Press Release: Genmab Announces Financial Results for the First Half of 2017". Copenhagen. 2017-08-09
Mologen AG. (8/9/17). "Press Release: Results of the Extension Phase of the Exploratory Phase Ib/IIa Study in HIV". 2017-08-09
Pieris Pharmaceuticals, Inc.. (8/9/17). "Press Release: Pieris Pharmaceuticals Reports Financial Results for the Second Quarter Ended June 30, 2017 and Provides Corporate Update". Boston, MA. 2017-08-09
Galapagos N.V.. (8/9/17). "Press Release: GLPG1690 Halts Disease Progression in IPF Patients in FLORA Phase 2a Trial". Mechelen. 2017-08-09
Zealand Pharma A/S. (8/9/17). "Presss Release: Zealand Pharma A/S Prices Its Initial Public Offering of American Depositary Shares on The Nasdaq Global Select Market in the United States". Copenhagen. 2017-08-09
Epigenomics AG. (8/9/17). "Presss Release: Epigenomics AG Announces 2017 Second Quarter and Six Months Financial Results". Berlin & Germantown, MD. 2017-08-09
H. Lundbeck A/S. (8/9/17). "Press Release: Lundbeck Reports 13% Revenue Growth and a Doubling of EBIT in First Half of 2017". Valby. 2017-08-09
Royal Philips. (8/9/17). "Presss Release: Philips Completes Acquisition of The Spectranetics Corporation". Amsterdam & Colorado Springs, CO. 2017-08-09
Pluristem Therapeutics Inc.. (8/9/17). "Presss Release: Israeli Government to Support Pluristem’s Marketing Activity in China – Ministry of Economy Awards Company “Smart Money” Grant". Haifa. 2017-08-09
AC Immune S.A.. (8/9/17). "Presss Release: AC Immune Reports Second Quarter 2017 Financial Results". Lausanne. 2017-08-09
Novo Nordisk A/S. (8/9/17). "Presss Release: Novo Nordisk Increased Reported Operating Profit by 8% in the First Six Months of 2017". 2017-08-09
InDex Pharmaceuticals AB. (8/9/17). "Presss Release: InDex Pharmaceuticals Receives Orphan Drug Designation for Pediatric Ulcerative Colitis in the US". 2017-08-09
Selvita S.A.. (8/8/17). "Presss Release: Selvita and The Leukemia & Lymphoma Society Announce Partnership to Advance SEL120 into Phase I for AML Patients". Krakow & Rye Brook. 2017-08-08
Oxford BioMedica plc. (8/7/17). "Press Release: Oxford BioMedica Announces MHRA Licence For Commercial Supply". London. 2017-08-07
Epigenomics AG. (8/7/17). "Presss Release: Epigenomics AG – Notice of Loss Pursuant to § 92 par. 1 AktG". 2017-08-07
KCR CRO GmbH. (8/7/17). "Presss Release: KCR Expands Its European Services with a New Office in Leeds, UK". Berlin. 2017-08-07
Lonza Group AG. (8/4/17). "Press Relase: Lonza Acquires Micro-Macinazione to Create the Global Leader in Micronization Capacity and Capabilities". Basel. 2017-08-04
Lonza Group AG. (8/4/17). "Press Relase: Lonza Prices EUR 700 Million and USD 200 Million Multi Tranche »Schuldschein« Loan". Basel. 2017-08-04
Celyad S.A.. (8/4/17). "Press Release: Celyad Announces New Agreements with Celdara Medical and Dartmouth College". Mont-Saint-Guibert. 2017-08-04
Bristol-Myers Squibb Company. (8/3/17). "Press Relase: Bristol-Myers Squibb to Acquire IFM Therapeutics to Strengthen Oncology Pipeline Focus on Innate Immunity". New York, NY & Boston, MA. 2017-08-03
Teva Pharmaceutical Industries Ltd.. (8/3/17). "Press Relase: Teva Reports Second Quarter 2017 Financial Results". Jerusalem. 2017-08-03
PerkinElmer, Inc.. (8/3/17). "Press Relase: PerkinElmer Announces Financial Results for the Second Quarter of 2017". Waltham, MA. 2017-08-03
PerkinElmer, Inc.. (8/3/17). "Press Relase: PerkinElmer Launches Clinical Whole Genome Sequencing Services". Waltham, MA. 2017-08-03
MorphoSys AG. (8/3/17). "Press Relase: MorphoSys Reports Significant Progress in Its Therapeutic Programs in Second Quarter of 2017". Planegg. 2017-08-03
Medigene AG. (8/3/17). "Press Relase: Medigene Reports Results of First Six Months 2017". Planegg. 2017-08-03
Merck KGaA. (8/3/17). "Press Relase: European Patent Office to Grant Merck’s Patent Application for CRISPR Technology". Darmstadt. 2017-08-03
Merck KGaA. (8/3/17). "Press Relase: Executive Board Changes at Merck". Darmstadt. 2017-08-03
Merck KGaA. (8/3/17). "Press Relase: Q2 2017 – Merck Sets Course for Future Growth". Darmstadt. 2017-08-03
DiaSorin S.p.A.. (8/3/17). "Press Relase: DiaSorin Group Reports Strong Growth in Revenues and Profitability in Q2 2017". Saluggia. 2017-08-03
Genkyotex S.A.. (8/3/17). "Press Release: Genkyotex’s GKT831 Shown to Delay Tumor Growth in Multiple Preclinical Models by Targeting Cancer Associated Fibroblasts". Archamps & Geneva. 2017-08-03
Idorsia Ltd.. (8/3/17). "Press Release: Idorsia Announces Half Year Results for 2017 – Successful Start of New Biopharmaceutical Company". Allschwil. 2017-08-03
Sygnis AG. (8/3/17). "Press Release: Sygnis AG Reports Financial Results for the Second Quarter and First Six Months of 2017". Madrid & Heidelberg. 2017-08-03
Evotec AG. (8/3/17). "Press Release: Evotec and Fraunhofer IME-SP Sign Strategic Collaboration on iPSC Technology". Hamburg. 2017-08-03
Eloxx Pharmaceuticals, Ltd.. (8/2/17). "Press Release: Eloxx Pharmaceuticals Secures US$8 Million Investment from LSP, Increasing Total Raised in Series C to US$38 million". San Diego, CA & Rehovot. 2017-08-02
AstraZeneca plc. (8/2/17). "Press Release: US FDA Accepts Regulatory Submission for Acalabrutinib and Grants Priority Review". 2017-08-02
TC BioPharm Ltd.. (8/2/17). "Press Release: TCB Selected for EU Horizon 2020 Funding to Progress Novel, Mass-market Cell Therapies to Clinical Trial". Scotland. 2017-08-02
Corbion N.V.. (8/2/17). "Press Release: Corbion Signs Agreement to Bid for Substantially All of the Assets of Innovative Microalgae Specialist TerraVia". 2017-08-02
H. Lundbeck A/S. (8/2/17). "Press Release: Lundbeck Collaborates on Large First-of-its Kind Study of Links between Genetics and Psychiatric Disorders". Valby. 2017-08-02
Indivumed GmbH. (8/2/17). "Press Release: MedStar Health Collaborates with Indivumed to Advance Precision Oncology Research". Hamburg. 2017-08-02
DBV Technologies S.A.. (8/2/17). "Press Release: DBV Technologies Initiates Phase III Study of Viaskin Peanut in Peanut-allergic Patients One to Three Years of Age". 2017-08-02
Cellectis S.A.. (8/2/17). "Press Release: Cellectis Reports Financial Results for 2nd Quarter and First Six Months 2017". New York, NY. 2017-08-02
Milestone Pharmaceuticals Inc.. (8/1/17). "Press Release: Milestone Pharmaceuticals Closes $55 Million Series C Financing". Montréal, QC. 2017-08-01
High-Tech Gründerfonds Management GmbH. (8/1/17). "Press Release: Specialty Biotech Company Advanced Enzymes Acquires HTGF Portfolio Company Evoxx Technologies". Monheim & Mumbai. 2017-08-01
Homology Medicines, Inc.. (8/1/17). "Press Release: Homology Medicines Announces $83.5 Million Series B Financing to Advance Lead Development Candidate and AMEnDR In Vivo Gene Editing Technology". Bedford, MA. 2017-08-01
Zyme Communications Ltd.. (8/1/17). "Press Relase: Zyme Communications Strengthens Team and Relocates Cambridge Office". Cambridge. 2017-08-01
AiCuris Anti-infective Cures GmbH. (8/1/17). "Press Relase: AiCuris Granted Fast Track Designation by U.S. FDA for Oral Pritelivir for Treatment of HSV Infections in Immunocompromised Adults". Wuppertal. 2017-08-01
GenSight Biologics S.A.. (8/1/17). "Press Relase: GenSight Biologics Completes Enrollment of RESCUE Phase III Study of GS010 in the treatment of Leber’s Hereditary Optic Neuropathy". Paris. 2017-08-01
AstraZeneca plc. (8/1/17). "Press Release: Acalabrutinib Granted Breakthrough Therapy Designation by US FDA for the Treatment of Patients with Mantle Cell Lymphoma". 2017-08-01
Horizon Discovery Group plc. (8/1/17). "Press Release: Horizon Discovery Announces Release of High Quality, Well Annotated CHO Genome Sequence to Drive Innovation in Bioproduction". Cambridge. 2017-08-01
Royal Philips. (8/1/17). "Press Release: Philips Completes Transaction with Profound Medical Corp.". Amsterdam. 2017-08-01
4SC AG. (8/1/17). "Press Release: 4SC AG Was Granted a Fundamental Composition of Matter Patent for 4SC-208 for the US". Planegg-Martinsried. 2017-08-01
Valneva S.E.. (8/1/17). "Press Release: Valneva Announces Expansion of its Management Board – Strengthening Senior Management for Future Growth". Lyon. 2017-08-01
Redx Pharma plc (in administration). (7/31/17). "Press Relase: Disposal of BTK Inhibitor Drug Development Program". 2017-07-31
Uniqure N.V.. (7/31/17). "Press Relase: Uniqure Reacquires Development and Commercialization Rights for its Gene Therapy Candidate in Hemophilia B". Lexington, MA & Amsterdam. 2017-07-31
Teva Pharmaceutical Industries Ltd.. (7/31/17). "Press Relase: Celltrion and Teva Announce U.S. FDA Acceptance of Biologics License Application for Proposed Biosimilar to Herceptin (trastuzumab)". Incheon & Jerusalem. 2017-07-31
Laboratory Corporation of America Holdings (LabCorp). (7/31/17). "Press Relase: LabCorp to Acquire Chiltern for approximately $1.2 Billion in Cash, Advancing Its Leadership in Drug Development". Burlington, NC, London & Wilmington, NC. 2017-07-31
AstraZeneca plc. (7/31/17). "Press Release: Imfinzi Granted Breakthrough Therapy Designation by US FDA for Patients with Locally-advanced Unresectable Non-small Cell Lung Cancer". 2017-07-31
Eurofins Scientific. (7/31/17). "Press Release: Eurofins Expands Its Offering and Footprint in Drug Discovery Services with the Acquisition of DiscoverX". 2017-07-31
Evotec AG. (7/30/17). "Press Release: Evotec to Acquire Aptuit, Expanding Leadership in External Innovation". Hamburg. 2017-07-30
iTeos Therapeutics S.A.. (7/28/17). "Press Release: iTeos Therapeutics Granted EUR 7.5 Million Non-Dilutive Funding by the Walloon Region". Gosselies. 2017-07-28
Evoxx Technologies GmbH. (7/28/17). "Press Release: Specialty Biotech Company Advanced Enzymes Acquires 100% Stake in Evoxx Technologies". Monheim & Mumbai. 2017-07-28
Grifols S.A.. (7/28/17). "Press Release: Grifols Increases Its Revenues by 12.3% to EUR 2,192 Million Driven by Growth of Its Main Divisions". Barcelona. 2017-07-28
Cosmo Pharmaceuticals N.V.. (7/28/17). "Press Release: Cosmo Half-Year Report 2017". Dublin. 2017-07-28
GenSight Biologics S.A.. (7/28/17). "Press Relase: GenSight Biologics Reports Interim Financial Results for the First Half of 2017". Paris. 2017-07-28
Idorsia Ltd.. (7/28/17). "Press Release: ACT-541468 (DORA) Meets Primary Endpoint in Phase 2 Program in Adult and Elderly Patients with Insomnia". Allschwil. 2017-07-28
Evotec AG. (7/27/17). "Press Release: Evotec Expands Collaboration with Storm Therapeutics on Its RNA Epigenetics Platform". Hamburg. 2017-07-27
High-Tech Gründerfonds Management GmbH. (7/27/17). "Press Release: High-Tech Gründerfonds (HTGF) and MBG invest in stimOS’ Mimicking Bone Technologies. Constance-based Start-Up Company Gains HTGF and MBG as Investors". 2017-07-27
Proteros Biostructures GmbH. (7/27/17). "Press Release: Proteros Enters into New Research Collaboration with Johnson & Johnson Innovation on Sub-class of Epigenetic targets". Dublin. 2017-07-27
AB Sciex (d/b/a Sciex). (7/27/17). "Press Release: Sciex Equipment Is Now Available Through a Wide Range of Flexible Financing Packages via Evosciences". Warrington. 2017-07-27
Eurofins Scientific. (7/27/17). "Press Release: Eurofins Strengthens Its Non-invasive Prenatal Testing Technology Portfolio with the Acquisition of a Majority Stake in LifeCodexx". 2017-07-27
AstraZeneca plc. (7/27/17). "Press Release: H1 2017 Results". 2017-07-27
AstraZeneca plc. (7/27/17). "Press Release: AstraZeneca and Merck Establish Strategic Oncology Collaboration". 2017-07-27
Complix N.V.. (7/27/17). "Press Release: Complix Announces Expanded Strategic Oncology Collaboration with MSD to Develop Cell-Penetrating Alphabodies". Hasselt. 2017-07-27
Qiagen N.V.. (7/27/17). "Press Release: Qiagen Reports Results for Second Quarter and First Half of 2017". Venlo. 2017-07-27
Boehringer Ingelheim. (7/27/17). "Press Release: Boehringer Ingelheim Starts Clinical Study on Interchangeability between its Adalimumab Biosimilar Candidate and Humira". Ingelheim. 2017-07-27
Galapagos N.V.. (7/27/17). "Press Release: Servier Licenses GLPG1972 in Osteoarthritis from Galapagos". Mechelen & Suresnes. 2017-07-27
Galapagos N.V.. (7/27/17). "Press Release: Solid Financials Support R&D Progress. First Half-year financial Results". Mechelen. 2017-07-27
Bavarian Nordic A/S. (7/27/17). "Press Release: Bavarian Nordic Announces Agreement with Janssen for the Development of Vaccine Regimens against HIV-1 and Hepatitis B". Copenhagen. 2017-07-27
Genkyotex S.A.. (7/27/17). "Press Release: Genkyotex Provides Business Update for Q2 2017". Archamps. 2017-07-27
Ablynx N.V.. (7/26/17). "Press Release: Ablynx Receives Fast Track Designation from the FDA for Caplacizumab for the Treatment of Acquired TTP". Ghent. 2017-07-26
GlaxoSmithKline plc. (7/26/17). "Press Release: GSK Delivers Further Progress in Q2 and Sets Out New Priorities for the Group". London. 2017-07-26
XL-protein GmbH. (7/26/17). "Press Release: Jazz Pharmaceuticals and XL-protein GmbH Enter Into a License Agreement on PASylation Technology to Develop Long-Acting Asparaginase Product Candidates". Freising. 2017-07-26
Royal Philips. (7/26/17). "Press Release: Philips and Italian Fatebenefratelli Hospital Sign Multiyear Strategic Partnership to Enable Family-centered Care for Mother and Child". Amsterdam & Rome. 2017-07-26
Cosmo Pharmaceuticals N.V.. (7/26/17). "Press Release: Cosmo Announces European Approval of Qolotag® for Sigmoidoscopies in IBD Patients". Dublin. 2017-07-26
Eurofins Scientific. (7/26/17). "Press Release: Eurofins Expands Its Leadership in Biopharmaceutical Services with the Acquisition of Advinus Therapeutics". 2017-07-26
TxCell S.A.. (7/26/17). "Press Release: TxCell – Financial Information for the 2nd Quarter of 2017". Valbonne. 2017-07-26
DiaSorin S.p.A.. (7/25/17). "Press Release: DiaSorin to Acquire ELISA Immunodiagnostic Business Portfolio and Associated Assets from Siemens Healthineers". Saluggia. 2017-07-25
GlaxoSmithKline plc. (7/25/17). "Press Release: Switching to a Dolutegravir Regimen from a Boosted Protease Inhibitor Regimen Maintained Viral Suppression and Improved Lipid Fractions in Patients with HIV and High Cardiovascular Risk". London. 2017-07-25
1 2 3 ... 70 71 72  next pagenext page



Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px